We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+21.9%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$57.6B
AUM Growth
+$7.69B
(+15%)
Cap. Flow
+$3.7B
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
40.22%
Holding
1,054
New
202
Increased
277
Reduced
473
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$3.4B |
| 2 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$885M |
| 3 |
Tesla
TSLA
|
+$252M |
| 4 |
Amazon
AMZN
|
+$156M |
| 5 |
CLVT.PRA
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$379M |
| 2 |
Sherwin-Williams
SHW
|
+$161M |
| 3 |
NVIDIA
NVDA
|
+$154M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$116M |
| 5 |
Boeing
BA
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Communication Services | 15.36% |
| 4 | Healthcare | 13.38% |
| 5 | Financials | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Parker-Hannifin
PH
$134B
| $43K | ﹤0.01% |
127
-157
| -55% | -$52K |
|
602
Stryker
SYK
$133B
| $43K | ﹤0.01% |
151
-62
| -29% | -$16.4K |
|
603
American Homes 4 Rent
AMH
$12.3B
| $42K | ﹤0.01% |
1,326
-1,109
| -46% | -$35.4K |
|
|
BNY
604
Bank of New York Mellon
BNY
$108B
| $42K | ﹤0.01% |
931
-337
| -27% | -$16.3K |
|
605
Cardinal Health
CAH
$55.5B
| $42K | ﹤0.01% |
556
+349
| +169% | +$26.3K |
|
606
KeyCorp
KEY
$24.3B
| $42K | ﹤0.01% |
3,350
+649
| +24% | +$11K |
|
607
Marvell Technology
MRVL
$187B
| $42K | ﹤0.01% |
963
+37
| +4% | +$1.56K |
|
608
Norfolk Southern
NSC
$75B
| $42K | ﹤0.01% |
198
+60
| +43% | +$13.9K |
|
609
Aon
AON
$75.7B
| $41K | ﹤0.01% |
131
-365
| -74% | -$113K |
|
610
Caterpillar
CAT
$385B
| $41K | ﹤0.01% |
177
+104
| +142% | +$25.1K |
|
611
Camden Property Trust
CPT
$11B
| $41K | ﹤0.01% |
395
+273
| +224% | +$31.1K |
|
|
DISH
612
DELISTED
DISH Network Corp.
DISH
| $41K | ﹤0.01% |
4,400
+1,661
| +61% | +$20.9K |
|
613
TE Connectivity
TEL
$62B
| $40K | ﹤0.01% |
308
+198
| +180% | +$25.1K |
|
614
Boston Scientific
BSX
$73.1B
| $39K | ﹤0.01% |
+785
| New | +$37K |
|
615
Gaming and Leisure Properties
GLPI
$12.5B
| $39K | ﹤0.01% |
+750
| New | +$39.1K |
|
616
argenx
ARGX
$54.2B
| $38K | ﹤0.01% |
102
+30
| +42% | +$11.1K |
|
617
Baxter International
BAX
$14.4B
| $38K | ﹤0.01% |
925
-338
| -27% | -$14.3K |
|
618
Everest Group
EG
$14.2B
| $38K | ﹤0.01% |
105
+39
| +59% | +$14K |
|
|
FISV
619
Fiserv Inc
FISV
$27.8B
| $38K | ﹤0.01% |
333
+206
| +162% | +$22.7K |
|
620
Revvity
RVTY
$12.9B
| $38K | ﹤0.01% |
+285
| New | +$37.5K |
|
621
Williams-Sonoma
WSM
$29.5B
| $38K | ﹤0.01% |
+622
| New | +$38.8K |
|
622
Brookfield Renewable
BEPC
$6.17B
| $37K | ﹤0.01% |
1,058
+1,013
| +2,251% | +$30.7K |
|
623
Healthpeak Properties
DOC
$14.4B
| $37K | ﹤0.01% |
1,702
+1,080
| +174% | +$26.8K |
|
624
Equity Residential
EQR
$24.7B
| $37K | ﹤0.01% |
+609
| New | +$37.4K |
|
625
Evergy
EVRG
$18.9B
| $37K | ﹤0.01% |
609
+99
| +19% | +$6.02K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2023 Portfolio in Review
As of Q1 2023, Loomis, Sayles & Company held 1,054 positions worth $57.6B, up 15% from $49.9B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Loomis, Sayles & Company deployed $3.7B of net new capital in Q1 2023, opening 202 new positions and adding to 277 existing holdings. Its largest new stake was Bank of America Series L: 2,835,020 shares worth $81.1M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Novartis, an estimated $379M trimmed.
- Loomis, Sayles & Company's largest Q1 2023 buy was Bank of America Series L: 2,835,020 shares worth $81.1M.
- Loomis, Sayles & Company added most to Tesla in Q1 2023, an estimated $252M increase.
- Loomis, Sayles & Company's biggest Q1 2023 reduction was Novartis, cutting an estimated $379M.
- Loomis, Sayles & Company fully exited Globus Medical in Q1 2023, selling an estimated $38M.
- Loomis, Sayles & Company's ten largest holdings make up 40% of its $57.6B portfolio in Q1 2023.
- Loomis, Sayles & Company opened 202 new positions and closed 81 in Q1 2023.
- Loomis, Sayles & Company's portfolio value rose 15% quarter-over-quarter to $57.6B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2023, filed 11 May 2023.